This application describes miRNAs that may be used as {HEAD ~ serum or plasma biomarkers} for characterizing {TAIL ~ prostate disease} in a patient 
for characterizing
This application describes miRNAs that may be used as { HEAD ~ serum or plasma biomarkers } for characterizing { TAIL ~ prostate disease } in a patient
OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH